Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,177,223
+$556,016 QoQ
Shares Held
16,600
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#1,426
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $16,730,523 across 16 Drug Manufacturers - General names. ABBV ranks #1 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
16,600 | $4,177,223 | |
| 2 | AMGN |
Amgen Inc
|
9,816 | $3,554,569 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
22,902 | $2,893,438 | |
| 4 | LLY |
ELI LILLY & Co
|
2,245 | $2,692,720 | |
| 5 | JNJ |
Johnson & Johnson
|
4,698 | $1,193,149 | |
| 6 | BIIB |
Biogen Inc.
|
2,634 | $569,101 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,884 | $396,655 | |
| 8 | PFE |
Pfizer Inc
|
16,318 | $392,937 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,177,223 | 16,600 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,621,207 | 16,650 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,820,808 | 16,722 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,929,696 | 16,972 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,203,057 | 17,256 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,597,248 | 17,169 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,077,230 | 17,317 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,415,613 | 17,296 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $2,937,279 | 17,125 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,168,357 | 17,399 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,772,258 | 17,889 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,687,402 | 18,029 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,429,046 | 18,029 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,889,218 | 18,129 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $2,979,926 | 18,439 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,485,434 | 18,519 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,856,280 | 18,649 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,034,536 | 18,719 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,990,850 | 22,089 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,411,864 | 22,359 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $2,361,497 | 20,965 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,279,653 | 21,065 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,011,205 | 18,770 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $1,649,582 | 18,833 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $1,382,570 | 14,082 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,199,840 | 15,748 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||